Trial Profile
A double blind, randomised, placebo controlled, parallel group study of Sativex in the treatment of subjects with pain due to diabetic neuropathy.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Jul 2020
Price :
$35
*
At a glance
- Drugs Nabiximols (Primary)
- Indications Diabetic nephropathies
- Focus Therapeutic Use
- 27 Jul 2020 Status changed from recruiting to completed.
- 31 May 2011 New trial record